California-Based Teal Health Raises $22M in Series A Funding

The round also saw participation from Emerson Collective, Forerunner, Serena Ventures, and MPower Partners.

The company will use the funding to expand its network of payor, health system, employer, provider, and brand partnerships, grow direct-purchase options, and hire across clinical, commercial, technology, and operations teams.

What is Teal Health?

Teal Health provides an at-home HPV cervical cancer screening service designed to make screening more accessible and convenient.

Its flagship product, the Teal Wand, is the first FDA-authorized self-collection device for at-home HPV cervical cancer screening. It allows women to collect samples at home without a speculum or an in-office visit.

Read More:AI Startup Confido Raises $55M in Series B Funding

Teal Health combines at-home sample collection with a telehealth visit. Results are delivered through a secure platform, with follow-up care available when needed.

How Much Funding Has Teal Health Raised?

Teal Health has raised $45 million in total funding following its Series A round.

The latest round brought in $22 million. The source does not provide details about the amounts or dates of previous funding rounds.

Who Invested in Teal Health’s Series A Round?

.406 Ventures led the $22 million Series A funding round.

Other participating investors included:

• Emerson Collective
• Forerunner
• Serena Ventures
• MPower Partners

Why the Funding Matters

Teal Health will use the new capital to expand partnerships with payors, health systems, employers, providers, and brands.

The company also plans to expand direct-purchase options for individuals and organizations and continue hiring across clinical, commercial, technology, and operational functions.

Who founded Teal Health?

Teal Health was founded in 2020 by Kara Egan and Ave Thakor.

The company is headquartered in San Francisco, California.

Leadership Comments

"We designed Teal for all women, whether they are behind on their screening or coming due. Screening is just too difficult today, whether that is finding an appointment, the time in your day to attend, or the physical discomfort. Women need an accurate, trusted alternative that makes it easy to screen," said Kara Egan, CEO and Co-Founder of Teal Health.

"Patients are demanding more convenient way's to access healthcare and Teal has proven that convenience does not have to come at the expense of accuracy," said Kathryn Taylor Reddy, Partner at .406 Ventures. With insurance coverage expanding in 2027, Teal Health is positioned to transform how million's of women receive essential preventive healthcare."

Market and Business Growth

Teal Health says nearly one in three U.S. women is not up to date on cervical cancer screening.

The company reports that 59% of women who choose Teal are underscreened.

Thousands of women have rated Teal Health's end-to-end screening experience an average of 4.95 out of 5, according to the company.

Teal Health is also preparing for January 2027 federal guidelines that will require most health plans to cover self-collection for cervical cancer screening.

What Happens Next?

Teal Health plans to expand its partnerships and direct-purchase options to make at-home screening available through more healthcare and consumer channels.

The company will also continue hiring across key functions as it expands its screening service and reaches more women.

Read More:Baselayer Raises $35M in Series A Funding Led by M13